This article examines the role of ozanimod in the treatment of relapsing multiple sclerosis (RMS), summarizing relevant clinical trial data with a focus on efficacy, safety and long-term outcomes. These findings are discussed alongside practical and clinical considerations to place ozanimod within the context of the current treatment landscape. Multiple sclerosis: Background and clinical considerations […]
Advertisement
Login
Sign Up FREE
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Register now for FREE Access
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.